| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0178 |
Injection, aflibercept, 1 mg |
7,970 |
6,469 |
$8.63M |
| 67028 |
Intravitreal injection of a pharmacologic agent |
28,116 |
22,404 |
$1.40M |
| 92134 |
|
44,481 |
37,811 |
$374K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
5,889 |
5,166 |
$210K |
| 92012 |
Ophthalmological services: medical examination and evaluation, intermediate, established patient |
9,150 |
7,751 |
$152K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
4,544 |
3,991 |
$108K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,836 |
3,392 |
$95K |
| J3590 |
Unclassified biologics |
1,372 |
868 |
$53K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
876 |
763 |
$49K |
| 92250 |
|
2,327 |
2,020 |
$44K |
| J9035 |
Injection, bevacizumab, 10 mg |
380 |
271 |
$20K |
| 67210 |
|
69 |
50 |
$18K |
| 92226 |
|
2,403 |
1,231 |
$16K |
| 92202 |
|
1,387 |
1,280 |
$10K |
| 92225 |
|
346 |
176 |
$4K |
| 92235 |
|
96 |
79 |
$2K |
| 92201 |
|
162 |
155 |
$2K |
| 92004 |
Ophthalmological services: medical examination and evaluation, comprehensive, new patient |
55 |
49 |
$2K |